Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.

Proceedings of the National Academy of Sciences of the United States of America
K MatsuzakiK Nishikawa

Abstract

Two monoclonal antibodies (mAbs) against bovine heparin-binding growth factor II (HBGF-II)/basic fibroblast growth factor (bFGF) were obtained from mouse hybridoma cell lines. They were highly specific for bFGF from bovine, human, and mouse sources and did not cross-react with bovine heparin-binding growth factor I (HBGF-I)/acidic fibroblast growth factor (aFGF). The immunoglobulin class and subclass of these mAbs were IgG1, K. The apparent dissociation constant (Kd) for bFGF of these mAbs ranged from 10(-9) to 10(-10) M. One mAb (bFM-2) also cross-reacted with heat-inactivated bFGF, while the other mAb (bFM-1) did not, suggesting that bFM-1 recognized the conformation of the bFGF molecule necessary for its biological activity. These mAbs inhibited growth of cultured bovine capillary endothelial cells in both the presence and absence of exogenous bFGF, indicating the autocrine action of this growth factor in in vitro growth of these cells. On the other hand, injection of these hybridoma cell lines s.c. into the backs of athymic mice resulted in development of highly vascularized solid tumors and a sustained high level of anti-bFGF activity in the blood of the tumor-bearing mice. These findings suggest that bFGF is not essential...Continue Reading

References

Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A B RobertsJ H Kehrl
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M Fràter-SchröderP Böhlen
Sep 1, 1987·Journal of Cellular Physiology·S L MassogliaD J Gospodarowicz
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A BairdR Guillemin
Mar 1, 1985·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·I E GoetzD N Krause
Sep 1, 1988·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·Y MasudaK Nishikawa
May 1, 1988·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·Y MatuoF Wada
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M KlagsbrunJ A Smith
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·I VlodavskyM Klagsbrun
Jan 1, 1986·Cold Spring Harbor Symposia on Quantitative Biology·J A AbrahamJ C Fiddes
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D MoscatelliD B Rifkin
Sep 1, 1986·Journal of Cellular Physiology·D Gospodarowicz, J Cheng
Apr 29, 1987·Biochemical and Biophysical Research Communications·A SommerD B Rifkin
Nov 16, 1987·FEBS Letters·R J SimpsonA W Burgess
Jul 31, 1986·Biochemical and Biophysical Research Communications·N UenoR Guillemin
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·F EschR Guillemin
Dec 17, 1985·Biochemical and Biophysical Research Communications·F EschR Guillemin
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D GospodarowiczP Böhlent

❮ Previous
Next ❯

Citations

Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Takayuki FurumatsuYoshifumi Ninomiya
Nov 1, 1994·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·W O TwalR M Leach
Feb 15, 1995·Journal of Neuroscience Research·Y J HouV K Menon
Sep 1, 1993·Cell and Tissue Research·O AmanoS Iseki
Jan 1, 1996·Breast Cancer Research and Treatment·A Wellstein, F Czubayko
Apr 1, 1996·Cellular and Molecular Neurobiology·K FuxeL F Agnati
Jan 1, 1991·Pharmacology & Therapeutics·C SunderkötterC Sorg
Sep 1, 1994·Pharmacology & Therapeutics·W Auerbach, R Auerbach
Nov 1, 1990·Trends in Pharmacological Sciences·T E Maione, R J Sharpe
Mar 1, 1994·Brain Research. Molecular Brain Research·M EndohJ A Wagner
Jul 1, 1996·Brain Research. Molecular Brain Research·E K SpeliotesS P Finklestein
Aug 1, 1994·Neuroscience·F Gómez-PinillaC W Cotman
Apr 1, 1993·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·V K VijayanL F Eng
Jan 1, 1990·Progress in Growth Factor Research·W Risau
Apr 1, 1991·Current Opinion in Biotechnology·A L Harris
Aug 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I TakanamiS Kodaira
Dec 5, 1997·Brain Research. Molecular Brain Research·T N LinC Y Hsu
May 1, 1997·Neurobiology of Aging·M BhatnagarK Fuxe
Jan 1, 1997·Molecular Medicine Today·P R Colville-Nash, D A Willoughby
May 12, 2004·Nature Reviews. Drug Discovery·Napoleone FerraraWilliam Novotny
Aug 1, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K MatsuzakiK Inoue
Jan 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C G Gay, J A Winkles
Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y NakanishiK Nishikawa
Jan 19, 2013·Tissue Engineering. Part a·Jonas LeijonMagnus Rosenquist
Nov 1, 1994·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Y MyokenK Takada
Jan 1, 1997·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Y MyokenK Takada
Apr 1, 1992·American Journal of Reproductive Immunology : AJRI·R J Torry, B J Rongish

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.